Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerPierre-Étienne Heudel, Jean-Luc Soubirou, Sylvie Chabaud et al.|ESMO Open|2021Cited by 35
Outcomes of men with HIV and germ cell cancer: Results from an international collaborative studyMarcus Hentrich, Christian Hoffmann, Markus Bickel et al.|Cancer|2021Cited by 2